Please login to the form below

Not currently logged in

GSK cuts 1,000 from US salesforce

GSK is to cut around 1,000 US sales jobs by the end of 2008

GlaxoSmithKline (GSK) is to cut around 1,000 US sales jobs by the end of 2008.

This 12 per cent reduction will see the number of sales reps employed by GSK in the US fall to around 7,500. The most affected will be reps dealing with primary care products.

The lack of new drugs, along with several flagship drugs facing imminent generic competition are key factors contributing to a pattern of job cuts seen in other leading pharmaceutical companies worldwide.

In October, PMLiVE reported that Swiss company Novartis is to cut 550 US sales jobs by 2010, while Merck plans to cut 7,200 posts worldwide and close three research facilities by the end of 2011.

5th November 2008


Featured jobs

Subscribe to our email news alerts


Add my company
dna Communications

Healthcare communications with unique thinking, insight and attitude...

Latest intelligence

Is the pharma business model ready for precision medicine?
Precision medicine promises to revolutionise patient outcomes and reduce costs for industry but is pharma ready for it? Blue Latitude Health co-founder Head of Strategy Fred Bassett explores the challenges...
The NHS and ABPI at 70: inching closer to the triple win
The NHS and UK pharma’s ABPI both turn 70 this year. After years of transactional relationships, there’s a will to work more closely - but friction on prices and value...
What pharma marketers can learn from behavioural science
Pharma behavioural science and traditional emotional marketing create a powerful mix of techniques that have impact on real lives....